Denmark · Delayed Price · Currency is DKK ViroGates Statistics
Total Valuation
ViroGates has a market cap or net worth of DKK 93.59 million. The enterprise value is 89.25 million.
| Market Cap | 93.59M |
| Enterprise Value | 89.25M |
Important Dates
The last earnings date was Thursday, November 6, 2025.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ViroGates has 7.73 million shares outstanding.
| Current Share Class | 7.73M |
| Shares Outstanding | 7.73M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 36.61% |
| Owned by Institutions (%) | n/a |
| Float | 2.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.60 |
| PB Ratio | 33.01 |
| P/TBV Ratio | 33.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.20 |
| EV / Sales | 11.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.81, with a Debt / Equity ratio of 1.69.
| Current Ratio | 1.81 |
| Quick Ratio | 1.53 |
| Debt / Equity | 1.69 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.93 |
Financial Efficiency
Return on equity (ROE) is -249.66% and return on invested capital (ROIC) is -78.20%.
| Return on Equity (ROE) | -249.66% |
| Return on Assets (ROA) | -55.33% |
| Return on Invested Capital (ROIC) | -78.20% |
| Return on Capital Employed (ROCE) | -193.42% |
| Revenue Per Employee | 1.15M |
| Profits Per Employee | -1.77M |
| Employee Count | 10 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 0.98 |
Taxes
| Income Tax | -902,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.74% in the last 52 weeks. The beta is 0.96, so ViroGates's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | +24.74% |
| 50-Day Moving Average | 11.27 |
| 200-Day Moving Average | 9.73 |
| Relative Strength Index (RSI) | 46.16 |
| Average Volume (20 Days) | 5,356 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ViroGates had revenue of DKK 8.07 million and -12.39 million in losses.
| Revenue | 8.07M |
| Gross Profit | 5.41M |
| Operating Income | -12.51M |
| Pretax Income | -13.29M |
| Net Income | -12.39M |
| EBITDA | n/a |
| EBIT | -12.51M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 9.12 million in cash and 4.78 million in debt, giving a net cash position of 4.34 million or 0.56 per share.
| Cash & Cash Equivalents | 9.12M |
| Total Debt | 4.78M |
| Net Cash | 4.34M |
| Net Cash Per Share | 0.56 |
| Equity (Book Value) | 2.84M |
| Book Value Per Share | n/a |
| Working Capital | 6.29M |
Cash Flow
| Operating Cash Flow | -5.92M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 67.09%, with operating and profit margins of -155.07% and -153.51%.
| Gross Margin | 67.09% |
| Operating Margin | -155.07% |
| Pretax Margin | -164.68% |
| Profit Margin | -153.51% |
| EBITDA Margin | n/a |
| EBIT Margin | -155.07% |
| FCF Margin | n/a |
Dividends & Yields
ViroGates does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -13.24% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |